David E. Clark
Direttore Tecnico/Scientifico/R&S presso Pulmagen Therapeutics (Synergy) Ltd.
Profilo
David E.
Clark is Director of CADD & Information Services for Argenta Discovery Ltd.
Previously, he worked with the CADD Group of Aventis and Rhone-Poulenc Rorer.
Dr. Clark received a degree from the University of Oxford and an MSc and a PhD from the Department of Information Studies at the University of Sheffield.
Posizioni attive di David E. Clark
Società | Posizione | Inizio |
---|---|---|
Pulmagen Therapeutics (Synergy) Ltd.
Pulmagen Therapeutics (Synergy) Ltd. Miscellaneous Commercial ServicesCommercial Services Pulmagen Therapeutics (Synergy) Ltd. develops therapeutics for respiratory diseases. It engages in developing various internal proprietary programs in chronic obstructive pulmonary disease, asthma, and cystic fibrosis. The company was founded in August 2000 and is headquartered in Stevenage, the United Kingdom. | Direttore Tecnico/Scientifico/R&S | - |
Precedenti posizioni note di David E. Clark
Società | Posizione | Fine |
---|---|---|
Rhone-Poulenc Rorer, Inc.
Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Rhone-Poulenc Rorer, Inc. discovers, develops and markets human pharmaceuticals. It operates in all major markets of the world. The company is headquartered in Collegeville, PA. | Corporate Officer/Principal | - |
Aventis Behring | Corporate Officer/Principal | - |
Formazione di David E. Clark
University of Oxford | Undergraduate Degree |
The University of Sheffield | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 3 |
---|---|
Pulmagen Therapeutics (Synergy) Ltd.
Pulmagen Therapeutics (Synergy) Ltd. Miscellaneous Commercial ServicesCommercial Services Pulmagen Therapeutics (Synergy) Ltd. develops therapeutics for respiratory diseases. It engages in developing various internal proprietary programs in chronic obstructive pulmonary disease, asthma, and cystic fibrosis. The company was founded in August 2000 and is headquartered in Stevenage, the United Kingdom. | Commercial Services |
Aventis Behring | Health Technology |
Rhone-Poulenc Rorer, Inc.
Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Rhone-Poulenc Rorer, Inc. discovers, develops and markets human pharmaceuticals. It operates in all major markets of the world. The company is headquartered in Collegeville, PA. | Health Technology |
- Borsa valori
- Insiders
- David E. Clark